Using in silico approaches, including molecular docking, ADMET profiling, molecular dynamics simulations, and MM-GBSA binding free energy calculations, this study assesses the binding affinity, pharmacokinetic properties, dynamic stability, and therapeutic potential of these compounds against EGFR in breast cancer. Here, EGFR is linked to breast cancer.